Editorial illustration for CBP seeks AI‑driven quantum sensors, tested by DHS, to detect fentanyl in cars
AI-Quantum Sensors Detect Fentanyl in Border Searches
The U.S. Customs and Border Protection wants a new weapon in the war on fentanyl: an AI‑driven quantum sensor that can sniff out narcotics from inside a car without ever opening a door. The technology sounds like science fiction.
But the agency has already tested versions of it, and the Department of Homeland Security has been evaluating handheld analyzers for years. The July request for information, however, conspicuously omits any mention of artificial intelligence or a database. It describes equipment that uses infrared and laser‑based spectroscopy to identify substances ranging from fentanyl to MDMA.
The justification from last week adds a twist: CBP claims it found a commercial device that cannot detect fentanyl, yet the manufacturer insists it can. Meanwhile, the “quantum” label remains undefined, though quantum‑chemistry‑based detection methods do exist. The stakes are clear: border seizures of opioids continue to climb.
DHS has also tested the Gemini in previous years, according to reports published in 2021 and 2023. The July request--which notes that the devices would be used to identify substances like fentanyl, ketamine, cocaine, methamphetamine, diazepam, and MDMA--makes no mention of artificial intelligence or a database. "The detection equipment will be used by CBP Officers in non-intrusive testing to detect a wide range of narcotics, controlled substances, unknown substances, and general organic materials," the request reads, noting that the agency "continues to seize an increasing number of opioids at the nation's borders." The July request for information claims that the Gemini analyzers use "Fourier Transform Infrared Spectroscopy (FTIR)," which measures how much infrared light a sample absorbs, and "Raman spectroscopy," which measures how light scatters off the surface of a sample when a laser is directed at it.
Last week's contract justification says that the agency found an American company that creates a "handheld analyzer" for identifying dangerous chemicals but claimed it "cannot detect fentanyl." It's unclear whether this was referring to Gemini or one of the more than 10 other devices DHS tested in 2021 and 2023. But when reached for comment, Thermo Fisher Scientific said that its Gemini analyzers "are designed to detect fentanyl." It's also unclear whether the General Dynamics prototype may use FTIR or Raman spectroscopy. But a 2024 working paper about a laboratory-based fentanyl-detection method (unrelated to CBP, General Dynamics, or Thermo Fisher Scientific) notes that "portable Raman spectrometers" and other handheld devices--though convenient, fast, and inexpensive--can "struggle with detection of fentanyl" and may be prone to "false-positive and false-negative results." While it remains ambiguous what exactly last week's justification was referring to with its mention of "quantum" sensors, there are fentanyl detection methods based in quantum chemistry.
Here’s the truth: the quest for a perfect fentanyl detector is a race against a moving target. Lasers, spectrometers, and databases are powerful, but they fail when the enemy is a single grain of powder hidden in a gas tank. That’s where the allure of quantum sensing lives, in its promise to see what photons miss.
Yet, the same documents that champion this next leap admit their current tools stumble. One vendor’s device can’t find fentanyl. Another’s tests yield false positives.
The human cost of those errors is immense: a car idles for hours, a shipment slips through, an officer gets exposed. So the push for AI quantum sensors isn’t just a technology upgrade, it’s a demand for certainty in an uncertain game. The science is nascent, the path is littered with half-solutions, and the agency is hedging its bets across multiple prototypes.
What’s clear is that CBP knows the price of guessing wrong. And they are betting that the only way to win is to see the invisible.
Related Reading
AI Tools & Apps Claude gains shared context in Excel, PowerPoint; Microsoft adds Copilot Cowork
AI Tools & Apps Windows Copilot AI unable to pinpoint image source in user test
AI Tools & Apps LG's recent webOS update adds Microsoft Copilot app, now removable
From Archives GitHub launches Copilot SDK, extending CLI AI to embed agents in apps
From Archives AI-Enabled Disinformation Swarms Threaten Democratic Governance
Common Questions Answered
What specific substances is CBP targeting with its new quantum sensor technology?
CBP is seeking to detect fentanyl, ketamine, cocaine, methamphetamine, diazepam, and MDMA using new detection equipment. The technology aims to identify these substances through non-intrusive testing in vehicles and containers, potentially leveraging quantum and classical sensing approaches.
How is General Dynamics involved in the new drug detection technology?
General Dynamics has been awarded a contract to build a prototype that combines quantum and classical sensing technologies with an artificial-intelligence-driven database. The contract specifically targets developing a system capable of detecting multiple controlled substances inside vehicles and containers.
What is unusual about the CBP's procurement request for the new drug detection device?
The procurement request notably lacks explicit details about the artificial intelligence component, despite the headline suggesting an AI-driven approach. While the technology aims to create a high-tech sensing solution, the official documentation provides minimal information about the AI or machine learning aspects of the system.
Further Reading
- Quantum Sensors with Database - SAM.gov — SAM.gov
- DHS announces new partnership to build fentanyl detection tools — FedScoop
- DIVISION C-DEPARTMENT OF HOMELAND SECURITY - Opioid and Fentanyl Detection — U.S. House of Representatives
